Previous studies have shown that increased expression of FOXM1 is highly associated with drug resistance, reduces cellular sensitivity, and protects cancer cells from induced apoptosis by chemotherapy agents (Xie et al., 2015; Zhou et al., 2013). The gene discussed is FOXM1; the disease is cancer.